These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 8560758

  • 1. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L, Wrona TJ, Dudley JP.
    Virology; 1996 Jan 15; 215(2):113-23. PubMed ID: 8560758
    [Abstract] [Full Text] [Related]

  • 2. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L, Wrona TJ, Dudley JP.
    Virology; 1997 Sep 15; 236(1):54-65. PubMed ID: 9299617
    [Abstract] [Full Text] [Related]

  • 3. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y, Wajjwalku W, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y.
    J Immunol; 1995 Jun 15; 154(12):6219-26. PubMed ID: 7759859
    [Abstract] [Full Text] [Related]

  • 4. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV, Dudley JP, Ross SR.
    J Immunol; 1998 Sep 01; 161(5):2375-82. PubMed ID: 9725233
    [Abstract] [Full Text] [Related]

  • 5. A congenic line of the BALB/c mouse strain with the endogenous mouse mammary tumor virus proviral gene Mtv-3: tissue-specific expression and correlation with resistance to mouse mammary tumor virus infection and tumorigenesis.
    Hainaut P, Castellazzi M, Gonzales D, Clausse N, Hilgers J, Crépin M.
    Cancer Res; 1990 Jun 15; 50(12):3754-60. PubMed ID: 2160325
    [Abstract] [Full Text] [Related]

  • 6. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I, Erny K, Acha-Orbea H, Diggelmann H.
    Eur J Immunol; 1996 May 15; 26(5):1000-6. PubMed ID: 8647159
    [Abstract] [Full Text] [Related]

  • 7. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N, Nishimura H, Wajjwalku W, Ando Y, Nagafuchi S, Watanabe T, Yoshikai Y.
    J Immunol; 1997 Sep 01; 159(5):2189-95. PubMed ID: 9278306
    [Abstract] [Full Text] [Related]

  • 8. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
    Barnett A, Mustafa F, Wrona TJ, Lozano M, Dudley JP.
    J Virol; 1999 Aug 01; 73(8):6634-45. PubMed ID: 10400761
    [Abstract] [Full Text] [Related]

  • 9. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ, Lozano M, Binhazim AA, Dudley JP.
    J Virol; 1998 Jun 01; 72(6):4746-55. PubMed ID: 9573239
    [Abstract] [Full Text] [Related]

  • 10. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ, Novick MB, Palmer LD, Knepper JE.
    J Immunol; 1993 Feb 15; 150(4):1422-8. PubMed ID: 8094408
    [Abstract] [Full Text] [Related]

  • 11. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD, Saha B, Hodes RJ, Abe R.
    J Immunol; 1996 Mar 15; 156(6):2112-8. PubMed ID: 8690899
    [Abstract] [Full Text] [Related]

  • 12. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U, McLellan B, Kraus E, Huber BT.
    Cell Immunol; 1996 Mar 15; 168(2):141-7. PubMed ID: 8640859
    [Abstract] [Full Text] [Related]

  • 13. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H.
    Eur J Immunol; 1994 Jul 15; 24(7):1612-9. PubMed ID: 7913038
    [Abstract] [Full Text] [Related]

  • 14. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM, Wallace VA, Timms E, Mak TW.
    Eur J Immunol; 1994 May 15; 24(5):1102-8. PubMed ID: 8181521
    [Abstract] [Full Text] [Related]

  • 15. [Coevolutive mechanisms between retroviruses and their hosts. The murine mammary tumor model].
    Nepomnaschy I, Buggiano V, Goldman A, Piazzon I.
    Medicina (B Aires); 1997 May 15; 57(2):235-44. PubMed ID: 9532836
    [Abstract] [Full Text] [Related]

  • 16. [Superantigens and murine mammary tumor retrovirus].
    Piazzon I, Nepomnaschy I, Buggiano V, Bekinschtein P, Goldman A, Berguer P, Deroche A, Lombardi G.
    Medicina (B Aires); 1997 May 15; 57 Suppl 2():21-33. PubMed ID: 9567341
    [Abstract] [Full Text] [Related]

  • 17. [Superantigens and retroviral infections. Increase of mammary tumorigenicity due to recombination between exogenous and endogenous MMTV viruses].
    Nepomnaschy I, Buggiano V, Goldman A, Deroche A, Bekinschtein P, Berguer P, Piazzon I.
    Medicina (B Aires); 1997 May 15; 57(3):327-31. PubMed ID: 9640768
    [Abstract] [Full Text] [Related]

  • 18. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens.
    Jarvis CD, Germain RN, Hager GL, Damschroder M, Matis LA.
    J Immunol; 1994 Feb 01; 152(3):1032-8. PubMed ID: 8301115
    [Abstract] [Full Text] [Related]

  • 19. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
    Kang J, Ido E, Pawling J, Beutner U, Huber BT, Hozumi N.
    J Immunol; 1994 Feb 01; 152(3):1039-46. PubMed ID: 8301116
    [Abstract] [Full Text] [Related]

  • 20. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
    Tovar Sepúlveda VA, Berdel B, Coffin JM, Reuss FU.
    Virology; 2000 Sep 15; 275(1):98-106. PubMed ID: 11017791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.